SIMPATHIC

SIMPATHIC is the abbreviation for “Accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology”. Our consortium for the EU-funded Project SIMPATHIC consists of 22 international partners spread across Europe and Canada, including patient organizations, patient training organizations, academic centers, research infrastructures, and companies. 

The partner in Portugal is the Faculty of Pharmacy of the University of Lisbon and led by the researcher Sofia de Oliveira Martins.

Visit the project's official website: https://simpathic.eu/